Treatment of Metastatic Thyroid Cancer with Radioiodine Following Preparation by Recombinant Human Thyrotropin

[1]  J. Jonklaas,et al.  Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[2]  J. Jonklaas,et al.  Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. , 2012, Thyroid : official journal of the American Thyroid Association.

[3]  M. Luster,et al.  Recombinant human thyrotropin: safety and quality of life evaluation. , 2012, Journal of endocrinological investigation.

[4]  S. Larson,et al.  Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH , 2011, The Journal of clinical endocrinology and metabolism.

[5]  A. Driedger,et al.  Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic thyroid cancer who could not elevate endogenous thyrotropin or be withdrawn from thyroxine. , 2006, Thyroid : official journal of the American Thyroid Association.

[6]  A. Karasik,et al.  Compliance with follow-up and the informative value of diagnostic whole-body scan in patients with differentiated thyroid carcinoma given recombinant human TSH. , 2004, European journal of endocrinology.

[7]  Michael R. Tuttle,et al.  Near-lethal respiratory failure after recombinant human thyroid-stimulating hormone use in a patient with metastatic thyroid carcinoma. , 2003, Thyroid : official journal of the American Thyroid Association.

[8]  B. Jarzab,et al.  Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  R. Clauss,et al.  Protocol for the Combined Diagnostic and Therapeutic Use of Recombinant Human Thyroid-Stimulating Hormone , 2003, Clinical nuclear medicine.

[10]  R. Dierckx,et al.  Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[11]  G. Lindstedt,et al.  Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone , 2002, Journal of endocrinological investigation.

[12]  S. Aslam,et al.  Use of recombinant human thyrotropin in a complicated case of metastatic papillary thyroid carcinoma. , 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  A. Pinchera,et al.  Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. , 2001, European journal of endocrinology.

[14]  S. Larson,et al.  Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and review of literature. , 2000, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[15]  Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma. , 2000, The Journal of clinical endocrinology and metabolism.

[16]  R. Kloos,et al.  Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions. , 2000, Thyroid : official journal of the American Thyroid Association.

[17]  E. Molinari,et al.  Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer. , 2000, Cancer biotherapy & radiopharmaceuticals.

[18]  W. Barker,et al.  Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic struma ovarii. , 2000, The Journal of clinical endocrinology and metabolism.

[19]  D. Van Roost,et al.  Recombinant human thyrotropin in thyroid cancer and hypopituitarism due to sella metastasis. , 1999, Thyroid : official journal of the American Thyroid Association.

[20]  M. Burge,et al.  Isolated thyrotropin deficiency secondary to primary empty sella in a patient with differentiated thyroid carcinoma: an indication for recombinant thyrotropin. , 1999, Thyroid : official journal of the American Thyroid Association.

[21]  T. Guise,et al.  Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain. , 1999, The Journal of clinical endocrinology and metabolism.

[22]  A. F. Stewart,et al.  Papillary thyroid carcinoma metastatic to the pituitary gland. , 1999, Thyroid : official journal of the American Thyroid Association.

[23]  C. Villabona,et al.  Blood volumes and renal function in overt and subclinical primary hypothyroidism. , 1999, The American journal of the medical sciences.

[24]  P. Perros.  Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience. , 1999, Journal of endocrinological investigation.

[25]  H. Macapinlac,et al.  Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin. , 1998, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[26]  S. Sherman,et al.  Prognosis and treatment of brain metastases in thyroid carcinoma. , 1997, The Journal of clinical endocrinology and metabolism.

[27]  L. Freeman,et al.  Treatment of Scan-Negative, Thyroglobulin-Positive Metastatic Thyroid Cancer Using Radioiodine 131I and Recombinant Human Thyroid Stimulating Hormone , 1997 .

[28]  N. Carrasco,et al.  Cloning and characterization of the thyroid iodide transporter , 1996, Nature.

[29]  C. Larsson,et al.  Alterations of p53 and expression of WAF1/p21 in human thyroid tumors. , 1996, Thyroid : official journal of the American Thyroid Association.